Alimta patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).


LILLY Antifolate combination therapies
May, 2022

(1 year, 4 months ago)

Alimta is owned by Lilly.

Alimta contains Pemetrexed Disodium.

Alimta has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Alimta are:

  • US7772209*PED

Alimta was authorised for market use on 04 February, 2004.

Alimta is available in powder;intravenous dosage forms.

The generics of Alimta are possible to be released after 24 May, 2022.

Drugs and Companies using PEMETREXED DISODIUM ingredient

Market Authorisation Date: 04 February, 2004

Treatment: NA


How can I launch a generic of ALIMTA before it's drug patent expiration?
More Information on Dosage

ALIMTA family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic